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Challenges of scale down model for disposable bioreactors: 
case studies on growth & product quality impacts
Jincai Li, Guangming Zhang, Huilin Zhu, Weichang Zhou
Bioprocess Development, WuXi AppTec, Shanghai, China. (li_jincai@wuxiapptec.com)
Case Study I: growth challenges when 
transferring process from 2000L stainless steel 
bioreactor to 2000L SUBs
Case Study 3: product quality challenges 
when scaling up from benchtop glass BR 
to 200L SUBs (with ambr to rescue!)
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Abstract
Despite wide-spread use of disposable bioreactors, 
there is a lack of well-established scale-down model for 
larger scale SUBs. Here we report a case of NS0 cell 
culture process transfer from 2000L stainless steel 
bioreactor (SST) to 2000L disposable bioreactor (SUB).  
Initial attempts in trying to grow the NS0 cells in the small 
scale 2D bags yielded non-satisfactory results, as growth 
was impacted by bag material type as well as by 
suppliers of the same bag material type. However, 3D 
bags of 50L and above proved to be supportive of the 
NS0 cell line growth. 
Even for cell lines that do not have growth issues in 
SUBs, surprising product quality difference between 
SUBs and traditional bench top glass bioreactors are still 
being observed, thus making the bench top glass 
bioreactors non-ideal as scale down models.  We report 
two cases where glycan profiles of the expressed 
antibody products show such dramatic differences.  In 
one case, extensive testing of glass bioreactors from 
various suppliers led to a particular type being able to 
mimic the glycan profiles from the SUB, whereas in the 
other case, alternative scale down model had to be 
identified and the process had to be modified to maintain 
the glycan profiles when scaling up to the 200L SUB.
Leachables & extractables on SUBs
 Concern on L&E for cell culture is one of the main 
challenges for SUB implementation 
 Impact of L&E for cell culture
 Patient safety: toxic effects on patients
 Process impact: cell culture performance impacts
Case Study 2: product quality challenges in 
bench top glass BR scale down models for 
2000L SUBs
•The authors would like to thank members of the cell culture 
process development group at WuXi AppTec for the contributions
•We would also like to thank members of the Protein Analytical 




Bag A- 1 Direct culture in Hyclone 2D 
bag
Bag A- 2 Media incubation @ 37C, 
48hr;  then  inoc to SF
Bag A- 3 Media  w/o cholesterol & 
insulin incubated @ 37C, 
48hr;  then add chol & 
insulin back;  inoc to SF
Bag A- 4 Water w/ 1x chol incubated
@ 37C, 48hr; then used to 



















































:Not tested                poor cell growth
:cell growth OK, but some not ideal
:cell growth slower than control





























Medium without cholesterol 
and insulin incubated at 37℃
for 48h in bag, and  Add C& I 
before culture
Water  with 1×cholesterol 
incubated in bag at 37℃ for 















Medium incubated in bags at 
37℃ for 48h; then inoc to SF
Challenges in growing NS0 cells in disposable bags
Some disposable 
bags do support 
growth
• Different bags have different 
materials & are made in 
different ways
• Even bags with same contact 
layer material had different 
impact on growth
• Other materials, e.g., 
additives, could have major 
impact
• Ex: HyClone’s new Aegis5-
14 film
Not all bags are the same
• Various attempts using vendor A 2D bags did not lead to satisfactory 
results
• The fact that other bags w/ the same ULDPE material supported 
growth was encouraging
• 2D bag might not be a good scale-down model of 3D & large volume 
bags
• Surface to volume ratio much larger
• If there are leachables, 2D bag would be worst case scenario
• Two options
• Try vendor A 50L SUB to see if growth is OK
• Try vendor B SUB 
Decision to try 50L SUB directly
• Culture performance in 50L SUB was 
comparable to 3L glass vessel and 
historical GMP data
• Indeed 2D bag was not a good scale-
down model
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1st 50L SUB showed good performance
• 250L SUB as last step before scaling up to 2000L SUB
• Process designed to mimic 2000L operation as much as possible
• Good performance at 250L SUB, with full analytical comparability 
assessment
• Cleared to scale-up to 2000L SUB
Case Study I (Cont’d)
Process confirmation at 250L SUB
 Successful scale-up to 2000L SUB
• Growth & productivity at 
2000L SUB (eng run & GMP 
run) matched very well with 
historical GMP data
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Productivity comparison between different scales
Unexpected challenge in glycosylation profiles
• Satellite cultures of 2000L SUB had 
dramatic difference in glycosylation
profiles
• One matched 2000L SUB well
• The other had significant 
differences
• Other performance indicators were 

















Unexpected challenge in scale-down model transfer
• Significant differences in glycan profiles among different small 
scale cultures
• Difference between 1L vs 3L model
• Even among 3L bioreactors, difference remained
• Glass vessel had same dimensions
• Agitator  diameter different
• Sparger different
• Baffle presence or not  also made a difference











3L F W/O Baffle
3L S W/ Baffle
3L S W/O Baffle
3L B W/ Baffle


























G0F% G1F% G1F′ % G2F% Total α-Gal%  Total SA%
Comparison between 2000L SUB and scale-
down model glycan profiles
2000L (n=5) scale down (n=18)















G0F Comparison Among Processes
• Much higher G0F
 Failed lot!
• More data revealed 
potential difference from 
plastic vs metal material
• N culture vessel material
• N-1/N-2 culture vessel 
material
Process development to fine-tune glycosylation 
profile
• Shake flasks and ambr15 microbioreactors (from TAP) 
were used for new process evaluation (not glass BR)
• Process identified to hit target G0F in ambr
• A single feed additive was shown to be very effective 
in adjusting glycan profiles

















































G0F% vs feed additive amount
Successful scale-up and confirmation at 200L SUB
Sample ID G0F(%)
Reference STD 69
Old process ambr 84.5
Optimized process ambr 68.7 
Old process 7L glass BR 74.0 
Optimized process 7L glass BR 40.1 
Old process 10L XDR 85.2 
Optimized process 10L XDR 64.7 
Old process 200L SUB 87.5 
Optimized process 200L SUB (n=3) 71.0 +/-2.0
Old process 200L satellite 3L glass BR 83.8 
New process 200L satellite 3L glass BR 52.9 




















Lack of good scale down models for 
SUBs
 None of the major suppliers of SUBs offer representative 
scale-down models of the larger scale SUBs
 50L SUBs appear to be the most appropriate models to 
represent 2000L scales.  But it is too expensive to be an 
economical model 
 Benchtop glass bioreactors are still being widely used as 
scale-down models for large scale SUBs.
 However, leachables & extratables can not be tested with 
glass bioreactors.  Product quality impact from SUBs also 
can not be evaluated with glass bioreactors 
Background: NS0 cell line with chemically-defined medium
Medium contains insulin & cholesterol
Robust process demonstrated by 2000L SST GMP runs
 Objective: transfer & scale-up to 2000L SUB for PhIII trials
 Various attempts in trying to grow the cells with the 2D 
Bag A did not succeed 
• Picked the BR model 
that’s closest to 2000L 
SUB data, and also most 
consistent product quality 
data
Background: biosimilar CHO cell culture process 
developed in benchtop glass BR
Objective: scale-up to 200L SUB
Surprise seen when process scaled up to 200L SUB
 Ambr microbioreactor (15mL scale) served as a good 
scale-down model for the 200L SUBs
 With the modified process, glycan profiles between 3L 
benchtop glass BR and the 200L SUB still had 
dramatic differences 
 GE’s Xcellerex 10L XDR did better than the glass 
BR, but not as good as ambr
